COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions
-
- Chris R. Triggle
- Department of Pharmacology, Weill Cornell Medicine-Qatar, Doha, Qatar
-
- Devendra Bansal
- Ministry of Public Health, Doha, Qatar
-
- Elmoubasher Abu Baker Abd Farag
- Ministry of Public Health, Doha, Qatar
-
- Hong Ding
- Department of Pharmacology, Weill Cornell Medicine-Qatar, Doha, Qatar
-
- Ali A. Sultan
- Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, Doha, Qatar
-
- Helene F. Rosenberg
- editor
説明
<jats:p>Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and first emerged in December 2019 in Wuhan, Hubei province, China. Since then, the virus has rapidly spread to many countries. While the outbreak in China appears to be in decline, the disease has spread across the world, with a daily increase in the number of confirmed cases and infection-related deaths. Here, we highlight (i) the lessons that have been learnt so far and how they will benefit reducing the impact of COVID-19 disease and (ii) an update on the status of drug treatment and vaccine development to prevent COVID-19 and potential future related pandemics.</jats:p>
収録刊行物
-
- mSphere
-
mSphere 5 (3), 2020-06-24
American Society for Microbiology
